Exelixis, Inc. Logo Image

Exelixis, Inc.

Most Recent Annual Report

2016 Annual Report and Form 10K

Exelixis, Inc.

Exelixis, Inc. does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

About Exelixis, Inc.

51-200 Employees
Based in San Francisco, California

Exelixis, Inc. engages in the discovery, development, and commercialization of small molecule drugs for the treatment of cancer, metabolic, and cardiovascular disorders. The company's compounds primarily target multiple receptor tyrosine kinases simultaneously.

Ticker:
EXEL
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol